Allevi became part of the 3D Systems family in 2021 as part of the company’s strategic growth in advanced bioprinting and regenerative medicine. Their mission is to make it easy to design and engineer 3D tissues.
Their 3D bioprinters and bioinks are used by leading researchers worldwide to find solutions to humanity’s most difficult problems—to cure disease, to test novel drugs, to eliminate the organ waiting list, to build with life. Allevi by 3D Systems builds tools to design and engineer with life.